Skip to main content
logo
Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
56.44
+0.44 (0.79%)
May 8, 2026, 4:00 PM EDT - Market closed

Xenon Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
5,4553,5862,9963,4722,4681,645
Market Cap Growth
86.55%19.71%-13.71%40.67%50.04%205.45%
Enterprise Value
4,1153,0442,3762,8431,8861,108
Last Close Price
56.4444.8239.2046.0639.4331.24
PE Ratio
--10.28-13.02-16.87-19.14-17.65
PEG Ratio
-2.512.512.512.512.51
PS Ratio
-478.14--261.5989.21
PB Ratio
3.686.163.973.743.422.99
P/TBV Ratio
3.446.114.053.323.312.48
P/FCF Ratio
--12.81-16.24-22.15-23.75-22.99
P/OCF Ratio
--12.85-16.51-22.97-24.43-23.67
EV/Sales Ratio
-405.82--199.8860.12
EV/EBITDA Ratio
--8.21-8.59-13.41-14.76-14.19
EV/EBIT Ratio
--8.16-8.51-13.28-14.60-14.03
EV/FCF Ratio
--10.87-12.88-18.14-18.15-15.49
Debt / Equity Ratio
0.000.010.010.010.010.01
Debt / EBITDA Ratio
-0.02-0.02-0.03-0.05-0.08-0.11
Debt / FCF Ratio
-0.02-0.03-0.05-0.07-0.10-0.11
Net Debt / Equity Ratio
-0.81-0.93-0.82-0.68-0.81-0.99
Net Debt / EBITDA Ratio
2.651.462.232.964.556.96
Net Debt / FCF Ratio
3.541.933.354.005.607.60
Asset Turnover
-0.01000.010.05
Quick Ratio
27.5313.1717.6623.4326.1238.72
Current Ratio
27.7913.4217.8523.6526.4439.03
Return on Equity (ROE)
-39.92%-51.76%-27.85%-22.12%-19.72%-21.87%
Return on Assets (ROA)
-40.65%-52.28%-31.14%-24.87%-19.49%-20.75%
Return on Invested Capital (ROIC)
-275.69%-413.38%-125.42%-97.01%-176.64%-2017.29%
Return on Capital Employed (ROCE)
-42.58%-55.11%-32.86%-25.65%-20.04%-21.58%
Earnings Yield
-7.02%-9.73%-7.68%-5.93%-5.22%-5.67%
FCF Yield
--7.81%-6.16%-4.51%-4.21%-4.35%
Buyback Yield / Dilution
-4.16%-1.74%-16.45%-10.48%-38.77%-26.30%
Total Shareholder Return
-4.16%-1.74%-16.45%-10.48%-38.77%-26.30%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q